MarkAtlasMD

Pediatric Hematology & Oncology • New Hyde Park, NY

Associate Professor, Pediatrics, Zucker School of Medicine at Hofstra-Northwell

Join to view full profile

Dr. Atlas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Atlas' full profile

Already have an account?

Office
Schneider Childrens Hospital
26901 76TH Avenue
New Hyde Park, NY 11040
Phone+1 718-470-3470

Fax+1 718-343-4642

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 1993 - 1996
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1989 - 1992
Albert Einstein College of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1996 - 2026
PA State Medical License 1991 - 1998
IL State Medical License 1993 - 1996
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Start of enrollment: 2005 Oct 01
Completed
Phase 2
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Start of enrollment: 2013 Oct 22
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

18 citations
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous...
Jason R. Fangusaro, Rima Jubran, Jeffrey C. Allen, Sharon Gardner, Ira J. Dunkel
Pediatric Blood & Cancer. 2008-03-01
52 citations
Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors
Michelle De Witt, Alexander J. Gamble, Derek Hanson, Daniel Markowitz, Caitlin Powell
Molecular Medicine. 2017-04-05
65 citations
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with ce...
Wafik Zaky, Girish Dhall, Lingyun Ji, Kelley Haley, Jeffrey C. Allen
Pediatric Blood & Cancer. 2014-01-01

Press Mentions

7-Year-Old Cancer Patient Returns to Cohen to Thank the Doctors Who Saved His LifeSeptember 25th, 2024

Other Languages

French, Spanish